MarketBeat Instant News Alerts 2 hours agoWeiss Ratings Reiterates Sell (E+) Rating for Veru (NASDAQ:VERU)MarketBeatWeiss Ratings reiterated a "sell (e+)" rating on shares of Veru in a research note on Friday.NASDAQ:VERURead Weiss Ratings Reiterates Sell (E+) Rating for Veru (NASDAQ:VERU)2 hours agoWeiss Ratings Reaffirms Sell (D) Rating for Vertex (NASDAQ:VERX)MarketBeatWeiss Ratings reiterated a "sell (d)" rating on shares of Vertex in a report on Friday.NASDAQ:VERXRead Weiss Ratings Reaffirms Sell (D) Rating for Vertex (NASDAQ:VERX)2 hours agoWeiss Ratings Reiterates "Sell (E+)" Rating for VinFast Auto (NASDAQ:VFS)MarketBeatWeiss Ratings reissued a "sell (e+)" rating on shares of VinFast Auto in a research report on Friday.NASDAQ:VFSRead Weiss Ratings Reiterates "Sell (E+)" Rating for VinFast Auto (NASDAQ:VFS)2 hours agoWeiss Ratings Reiterates "Sell (E+)" Rating for Verde Clean Fuels (NASDAQ:VGAS)MarketBeatWeiss Ratings restated a "sell (e+)" rating on shares of Verde Clean Fuels in a research note on Friday.NASDAQ:VGASRead Weiss Ratings Reiterates "Sell (E+)" Rating for Verde Clean Fuels (NASDAQ:VGAS)2 hours agoViavi Solutions' (VIAV) Hold (C-) Rating Reaffirmed at Weiss RatingsMarketBeatWeiss Ratings reaffirmed a "hold (c-)" rating on shares of Viavi Solutions in a report on Friday.NASDAQ:VIAVRead Viavi Solutions' (VIAV) Hold (C-) Rating Reaffirmed at Weiss Ratings2 hours agoVicor (NASDAQ:VICR) Given Hold (C) Rating at Weiss RatingsMarketBeatWeiss Ratings reaffirmed a "hold (c)" rating on shares of Vicor in a research report on Friday.NASDAQ:VICRRead Vicor (NASDAQ:VICR) Given Hold (C) Rating at Weiss Ratings Trending News1D-Wave Quantum (NYSE:QBTS) Stock Price Down 6.2% - Here's Why2Oracle (NYSE:ORCL) EVP Sells $1,403,100.00 in Stock3Oracle (NYSE:ORCL) Stock Price Down 4.9% - Here's What Happened4Nebius Group (NBIS) to Release Earnings on Wednesday5Plug Power (NASDAQ:PLUG) Shares Down 8.2% - Here's Why6Rolls-Royce Holdings plc (LON:RR) Shares Down 2.8% - Here's What Happened7Nebius Group (NASDAQ:NBIS) Shares Down 3.9% - Time to Sell?8Verizon Communications (NYSE:VZ) Stock Price Down 1.1% Following Analyst Downgrade All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoViomi Technology (NASDAQ:VIOT) Receives Sell (D+) Rating from Weiss RatingsMarketBeatNASDAQ:VIOTRead Viomi Technology (NASDAQ:VIOT) Receives Sell (D+) Rating from Weiss Ratings2 hours agoWeiss Ratings Reiterates Hold (C) Rating for Virco Manufacturing (NASDAQ:VIRC)MarketBeatNASDAQ:VIRCRead Weiss Ratings Reiterates Hold (C) Rating for Virco Manufacturing (NASDAQ:VIRC)2 hours agoVital Farms (NASDAQ:VITL) Upgraded at Weiss RatingsMarketBeatNASDAQ:VITLRead Vital Farms (NASDAQ:VITL) Upgraded at Weiss Ratings2 hours agoViking Therapeutics' (VKTX) "Sell (D-)" Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:VKTXRead Viking Therapeutics' (VKTX) "Sell (D-)" Rating Reaffirmed at Weiss Ratings2 hours agoWeiss Ratings Reaffirms Hold (C+) Rating for Valley National Bancorp (NASDAQ:VLY)MarketBeatNASDAQ:VLYRead Weiss Ratings Reaffirms Hold (C+) Rating for Valley National Bancorp (NASDAQ:VLY)2 hours agoVimeo's (VMEO) "Hold (C-)" Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:VMEORead Vimeo's (VMEO) "Hold (C-)" Rating Reaffirmed at Weiss Ratings2 hours agoWeiss Ratings Reiterates "Sell (D-)" Rating for Vanda Pharmaceuticals (NASDAQ:VNDA)MarketBeatNASDAQ:VNDARead Weiss Ratings Reiterates "Sell (D-)" Rating for Vanda Pharmaceuticals (NASDAQ:VNDA)2 hours agoViper Energy's (VNOM) "Hold (C)" Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:VNOMRead Viper Energy's (VNOM) "Hold (C)" Rating Reaffirmed at Weiss Ratings2 hours agoWeiss Ratings Reiterates "Sell (D-)" Rating for Vera Bradley (NASDAQ:VRA)MarketBeatNASDAQ:VRARead Weiss Ratings Reiterates "Sell (D-)" Rating for Vera Bradley (NASDAQ:VRA)2 hours agoViridian Therapeutics' (VRDN) "Sell (D-)" Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:VRDNRead Viridian Therapeutics' (VRDN) "Sell (D-)" Rating Reaffirmed at Weiss Ratings2 hours agoVAREX IMAGING's (VREX) "Sell (D)" Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:VREXRead VAREX IMAGING's (VREX) "Sell (D)" Rating Reaffirmed at Weiss Ratings2 hours agoVaronis Systems' (VRNS) "Sell (D-)" Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:VRNSRead Varonis Systems' (VRNS) "Sell (D-)" Rating Reaffirmed at Weiss Ratings2 hours agoVerint Systems (NASDAQ:VRNT) Earns "Sell (D+)" Rating from Weiss RatingsMarketBeatNASDAQ:VRNTRead Verint Systems (NASDAQ:VRNT) Earns "Sell (D+)" Rating from Weiss Ratings2 hours agoVERRA MOBILITY (NASDAQ:VRRM) Earns Hold (C-) Rating from Weiss RatingsMarketBeatNASDAQ:VRRMRead VERRA MOBILITY (NASDAQ:VRRM) Earns Hold (C-) Rating from Weiss Ratings2 hours agoVerisk Analytics (NASDAQ:VRSK) Rating Lowered to "Hold (C+)" at Weiss RatingsMarketBeatNASDAQ:VRSKRead Verisk Analytics (NASDAQ:VRSK) Rating Lowered to "Hold (C+)" at Weiss Ratings2 hours agoWeiss Ratings Reaffirms Buy (B-) Rating for VeriSign (NASDAQ:VRSN)MarketBeatNASDAQ:VRSNRead Weiss Ratings Reaffirms Buy (B-) Rating for VeriSign (NASDAQ:VRSN)2 hours agoVertex Pharmaceuticals' (VRTX) Hold (C+) Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:VRTXRead Vertex Pharmaceuticals' (VRTX) Hold (C+) Rating Reiterated at Weiss Ratings2 hours agoViasat (NASDAQ:VSAT) Receives "Sell (D-)" Rating from Weiss RatingsMarketBeatNASDAQ:VSATRead Viasat (NASDAQ:VSAT) Receives "Sell (D-)" Rating from Weiss Ratings2 hours agoVasta Platform's (VSTA) "Hold (C-)" Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:VSTARead Vasta Platform's (VSTA) "Hold (C-)" Rating Reiterated at Weiss Ratings2 hours agoWeiss Ratings Reaffirms Sell (D-) Rating for Verastem (NASDAQ:VSTM)MarketBeatNASDAQ:VSTMRead Weiss Ratings Reaffirms Sell (D-) Rating for Verastem (NASDAQ:VSTM)2 hours agoVistaGen Therapeutics' (VTGN) Sell (D-) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:VTGNRead VistaGen Therapeutics' (VTGN) Sell (D-) Rating Reaffirmed at Weiss Ratings2 hours agoWeiss Ratings Reiterates "Sell (D+)" Rating for VirTra (NASDAQ:VTSI)MarketBeatNASDAQ:VTSIRead Weiss Ratings Reiterates "Sell (D+)" Rating for VirTra (NASDAQ:VTSI)2 hours agoWeiss Ratings Reaffirms "Sell (D-)" Rating for Ventyx Biosciences (NASDAQ:VTYX)MarketBeatNASDAQ:VTYXRead Weiss Ratings Reaffirms "Sell (D-)" Rating for Ventyx Biosciences (NASDAQ:VTYX)2 hours agoWeiss Ratings Reaffirms Sell (D+) Rating for Wendy's (NASDAQ:WEN)MarketBeatNASDAQ:WENRead Weiss Ratings Reaffirms Sell (D+) Rating for Wendy's (NASDAQ:WEN) Featured Articles and OffersJPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall?By Leo Miller | October 19, 2025An $8 trillion-dollar discovery 17,000 ft underwater From Porter & Company (Ad)Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done YetBy Dan Schmidt | October 20, 2025Archer’s Recent String of Victories Signals a New Phase of GrowthBy Jeffrey Neal Johnson | October 22, 2025The Best AI for Picking Stocks, Ranked by PerformanceBy Thomas Hughes | October 23, 2025INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffFrom Traders Agency (Ad)2 Ways to Trade Qualcomm Ahead of November’s EarningsBy Sam Quirke | October 21, 2025Warner Bros. Bidding War Potential: How High Could WBD Shares Go?By Leo Miller | October 23, 2025 Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
